EarlySense

Description

EarlySense is the global leader in contact-free, continuous monitoring solutions for the healthcare continuum. Used worldwide in hospitals, post-acute care facilities, and homes, EarlySense assists clinicians in early detection of patient deterioration. The solution has been proven to help prevent adverse events, including code blue events which are a result of cardiac or respiratory arrest, preventable ICU transfers, patient falls, pressure ulcers, and hospital readmissions. EarlySense's FDA-cleared solutions leverage Artificial Intelligence (AI) and big data analytics to provide actionable health insights and improve clinical outcomes. The company has partnered with leading global technology companies including Samsung, Welch Allyn, Philips, Hill-Rom and Beurer. EarlySense is based in Ramat Gan, Israel and Woburn, Massachusetts.

A cookie is a piece of information that is downloaded and stored on your device when you visit a particular website. The cookie stores information that can later be read back from the sites or third parties. Cookies are used to recognize your browser, make more efficient the navigation, store your preferences, and generally improve your browsing experience. In some cases, some of these cookies are necessary for the proper operation of this website. NOAH encourages you to read our Cookies Statement. NOAH considers as accepted by you our Cookie Statement if you continue using our websites.OkLearn More